Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.

Traverse, Jay H; Henry, Timothy D; Moye', Lemuel A

Traverse, Jay H; Henry, Timothy D; Moye', Lemuel A.

Affiliation

Traverse JH; The Minneapolis Heart Institute at Abbott Northwestern Hospital, MN 55407, USA. trave004@umn.edu

Am Heart J ; 162(4): 671-7, 2011 Oct.

Article in En | MEDLINE | ID: mdl-21982659

Subject(s)

Bone Marrow Transplantation; Monocytes/transplantation; Myocardial Infarction/diagnosis; Myocardial Infarction/surgery; Randomized Controlled Trials as Topic/standards; Stem Cell Transplantation; Stroke Volume; Humans; Magnetic Resonance Imaging; Myocardial Infarction/physiopathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke Volume / Monocytes / Randomized Controlled Trials as Topic / Bone Marrow Transplantation / Stem Cell Transplantation / Myocardial Infarction Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Am Heart J Year: 2011 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google